Key Market Indicators
Sales of digestive system disorder medicines in Denmark are expected to reach $463 million by 2026, up from $419 million in 2021. This indicates an average annual growth rate of 1.6%. Since 2002, the Danish market has seen an annual rise of 5%. In 2021, the Czech Republic ranked first in the country rankings, at $419 million. Japan, South Korea and Canada were ranked second, third and fourth respectively.
